(Q43532238)

24 November 2017

title

Ipilimumab-induced perforating colitis (English)

1 reference

24 November 2017

0 references

3

Mario Sznol

1 reference

24 November 2017

Kisha A Mitchell

1

1 reference

24 November 2017

Harriet Kluger

series ordinal

2

1 reference

24 November 2017

Douglas J Hartman

series ordinal

4

1 reference

24 November 2017

publication date

1 October 2013

1 reference

Journal of Clinical Gastroenterology

24 November 2017

published in

1 reference

24 November 2017

volume

47

1 reference

24 November 2017

issue

9

1 reference

24 November 2017

page(s)

781-785

1 reference

The blockade of immune checkpoints in cancer immunotherapy

24 November 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

CTLA-4: new insights into its biological function and use in tumor immunotherapy

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6091636

Atypical presentation of colon perforation related to corticosteroid use

3 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23632354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/MCG.0B013E31828F1D51

1 reference

24 November 2017

0 references

1 reference